PMDA — authorised 23 March 2021
- Marketing authorisation holder: Mitsubishi Tanabe Pharma Corporation
- Status: approved
🇯🇵 Uplizna in Japan
PMDA authorised Uplizna on 23 March 2021
Marketing authorisation
Uplizna in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Japan
Frequently asked questions
Is Uplizna approved in Japan?
Yes. PMDA authorised it on 23 March 2021.
Who is the marketing authorisation holder for Uplizna in Japan?
Mitsubishi Tanabe Pharma Corporation holds the Japanese marketing authorisation.